2370 Stock Overview
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Zhejiang Yatai Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.28 |
| 52 Week High | CN¥5.28 |
| 52 Week Low | CN¥2.63 |
| Beta | 0.56 |
| 1 Month Change | -9.14% |
| 3 Month Change | -3.24% |
| 1 Year Change | -24.60% |
| 3 Year Change | -19.61% |
| 5 Year Change | -81.63% |
| Change since IPO | -48.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2370 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 4.5% | 5.7% | 4.2% |
| 1Y | -24.6% | -11.0% | -13.2% |
Return vs Industry: 002370 underperformed the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 002370 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 2370 volatility | |
|---|---|
| 2370 Average Weekly Movement | 7.6% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002370 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002370's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 528 | Xiaoming Huang | www.ytyaoye.com |
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers tablets, capsules, patches, powder injections, freeze-dried powders, and troches. It also provides pharmaceutical research and development services.
Zhejiang Yatai Pharmaceutical Co., Ltd. Fundamentals Summary
| 2370 fundamental statistics | |
|---|---|
| Market cap | CN¥2.00b |
| Earnings (TTM) | -CN¥12.26m |
| Revenue (TTM) | CN¥409.77m |
4.9x
P/S Ratio-163.0x
P/E RatioIs 2370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2370 income statement (TTM) | |
|---|---|
| Revenue | CN¥409.77m |
| Cost of Revenue | CN¥287.18m |
| Gross Profit | CN¥122.59m |
| Other Expenses | CN¥134.85m |
| Earnings | -CN¥12.26m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.02 |
| Gross Margin | 29.92% |
| Net Profit Margin | -2.99% |
| Debt/Equity Ratio | 110.1% |
How did 2370 perform over the long term?
See historical performance and comparison